421385596

ABCB1 as predominant resistance mechanism in cells with acquired SNS-032 resistance / Nadine Löschmann, Martin Michaelis, Florian Rothweiler, Yvonne Voges, Barbora Balónová, Barry A. Blight, Jindrich Cinatl

Löschmann, Nadine [Verfasser] ; Michaelis, Martin [Verfasser] ; Rothweiler, Florian,i1978- [Verfasser] ; Voges, Yvonne [Verfasser] ; Balónová, Barbora [Verfasser] ; Blight, Barry A. [Verfasser] ; Cinatl, Jindrich [Verfasser]

The CDK inhibitor SNS-032 had previously exerted promising anti-neuroblastoma activity via CDK7 and 9 inhibition. ABCB1 expression was identified as major determinant of SNS-032 resistance. Here, we investigated the role of ABCB1 in acquired SNS-032 resistance. In contrast to ABCB1-expressing UKF-NB-3 sub-lines resistant to other ABCB1 substrates, SNS-032-adapted UKF-NB-3 (UKF-NB-3rSNS- 032300nM) cells remained sensitive to the non-ABCB1 substrate cisplatin and were completely re-sensitized to cytotoxic ABCB1 substrates by ABCB1 inhibition. Moreover, UKF-NB-3rSNS-032300nM cells remained similarly sensitive to CDK7 and 9 inhibition as UKF-NB-3 cells. In contrast, SHEPrSNS-0322000nM, the SNS-032-resistant sub-line of the neuroblastoma cell line SHEP, displayed low level SNS-032 resistance also when ABCB1 was inhibited. This discrepancy may be explained by the higher SNS-032 concentrations that were used to establish SHEPrSNS-0322000nM cells, since SHEP cells intrinsically express ABCB1 and are less sensitive to SNS-032 (IC50 912 nM) than UKF-NB-3 cells (IC50 153 nM). In conclusion, we show that ABCB1 expression represents the primary (sometimes exclusive) resistance mechanism in neuroblastoma cells with acquired resistance to SNS-032. Thus, ABCB1 inhibitors may increase the SNS-032 efficacy in ABCB1-expressing cells and prolong or avoid resistance formation.

OncoTarget. - [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010-. - Online-Ressource. - ISSN 1949-2553. - Band 7, Heft 36 (2016), Seite 58051-58064

 

Je nach Lizenzbedingungen können Sie ggf. nicht über alle unten angegebenen Links auf den Volltext zugreifen. Die für Sie gültige URL finden Sie im Bestandsinfo Ihrer Bibliothek.